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1Chapter
Tips and Pitfalls in Robotic Mitral 
Valve Surgery
Takashi Murashita
Abstract
Robotic mitral valve repair is now routinely and safely performed all over the 
world. There are many literatures which showed advantages of reduced blood loss, 
lower risk of infection, lower risk of atrial fibrillation, shorter length of hospital 
stay, quicker return to normal activities, and a superior cosmetic result, compared 
with a conventional sternotomy. However, the introduction of new technique 
requires a learning curve even for expert mitral valve surgeons. There are complica-
tions specifically related to robotic mitral valve surgery, such as major vascular 
complications, inadequate myocardial protection, and unilateral pulmonary edema. 
The purpose of this chapter is to characterize the tips and pitfalls of robotic mitral 
valve repair and to discuss the controversial issues in the contemporary practice.
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1. Introduction
Since the introduction of robotic mitral valve repair in the late 1990s, the num-
ber of this procedure has been increasing worldwide. Many centers have reported 
excellent outcomes of robotic mitral valve repair [1–8]. In the beginning, it was 
mainly applied in selected patients with a simple repair case and relatively low risk 
cases. However, with the accumulation of surgical experience, the indication has 
been broadened to complicated repair cases or aged patients.
Wang et al. reviewed the Society of Thoracic Surgeons database and compared 
surgical outcomes of robotic and surgical mitral valve repair in patients aged 
65 years and older [9]. They found that robotic mitral valve repair was associ-
ated with less postoperative atrial fibrillation, less blood transfusion, and shorter 
intensive care unit and hospital stay compared with surgical mitral valve repair 
without a difference in 3-year mortality, heart failure readmission, or mitral valve 
reintervention.
2. Tips and pitfalls
2.1 Applying to a robot platform
Robotic mitral valve repair is usually done thorough a right thoracotomy; thus, 
intra-thoracic pathology such as previous right thoracotomy, severe pulmonary 
dysfunction, and chest deformity can be a contraindication [10]. Patients at risk 
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for coronary artery disease should undergo a cardiac catheterization, and severe 
coronary artery disease requiring coronary artery bypass grafting is another contra-
indication of robotic mitral valve repair. In addition, significant pulmonary hyper-
tension or severe right ventricular dysfunction is included to contraindications.
Usually, robotic mitral valve repair is done with a 5- to 6-cm right thoracotomy 
[11]. A specific attention should be paid for inserting robotic instruments into 
the right chest. The insertion of service ports can injure the right lung, vessels, 
diaphragm, liver, and mediastinal structures. Figure 1 shows our regular setup for 
robotic instruments. The thoracotomy is made through fourth or fifth intercostal 
space. We carefully review the preoperative computer tomography and decide 
which intercostal space would give us the best exposure for mitral valve. The port 
for left arm is usually inserted through second or third intercostal space. The port 
for left atrial retractor is usually inserted through the same intercostal space with 
thoracotomy. The port for right arm is usually inserted through sixth or seventh 
intercostal space. The camera port is inserted one higher intercostal space than 
thoracotomy.
2.2 The interaction between the operator and the assistance
After the robotic instruments are inserted, the surgeon moves to the robotic 
console, and the assistant will move to the patient’s right side and has an access to 
the operative field through the thoracotomy. From the console, the surgeons can 
perform precise movements inside the heart using the mechanical instruments. The 
mechanical instruments include forceps, scissors, needle holders, and electrocau-
tery. The surgeons use two mechanical instruments, and the changes of the instru-
ments were manipulated by the bedside assistant.
The role of the surgeon on console is to accomplish a mitral valve repair by 
cutting, suturing, and sizing with two mechanical instruments, whereas, the role of 
bedside assistant is suctioning the field, suture following, and knot tying. Since the 
operative field is very limited, the bedside assistant should be trained for knot-tying 
instruments.
Figure 1. 
The picture of a standard setup for robotic mitral valve surgery.
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2.3 Establishment of a cardiopulmonary bypass
In a robotic mitral valve repair, cardiopulmonary bypass is established either 
via an antegrade perfusion with a central cannulation or via a retrograde perfusion 
with a peripheral cannulation. It is a controversy in which perfusion strategy is 
optimal [12].
Murzi et al. reviewed 1421 patients who underwent antegrade perfusion and 141 
patients who underwent retrograde perfusion [13]. They reported that retrograde 
perfusion was associated with higher incidence of stroke than antegrade perfusion 
(3.5 vs. 1.1%). In the meantime, LaPietra et al. reviewed 1501 patients, and found 
that stroke rate was low (about 1.5%) regardless of cannulation technique [14]. 
Nowadays, several experienced centers routinely apply retrograde femoral perfu-
sion during minimally invasive mitral valve surgery [1, 3, 6].
In establishing the peripheral cannulation, the venous drainage for cardiopul-
monary bypass is obtained by a placement of cannula, usually via the right femoral 
vein and right internal jugular vein. It is essential to introduce cannula under a 
transesophageal echocardiography to avoid the risk of extravasation, migration 
of the cannula, or other types of complications [15]. Arterial cannula is usually 
inserted to the right femoral artery. It is also essential to obtain a preoperative 
multidetector computed tomography angiography for the assessment of aortoiliac 
atherosclerosis in order to plan an optimal surgical approach [16].
2.4 Aortic cross-clamp
For aortic cross-clamp, there are basically two options: endoaortic or trans-
thoracic clamp (Figure 2). The endoaortic cross-clamp is performed with an 
Figure 2. 
Left: endoaortic cross-clamping with an endoaortic balloon. Right: transthoracic cross-clamping using a 
Chitwood clamp.
Cardiac Surgery Procedures
4
endoaortic balloon, which comprises a triple lumen catheter mostly introduced 
usually through a left femoral artery with an inflatable balloon at the tip. The 
central lumen is used for delivery of cardioplegia and aortic root vent. The remain-
ing lumen is used for balloon inflation and deflation as well as pressure monitoring. 
The transthoracic clamp is called Chitwood clamp, and is introduced through the 
intercostal space and positioned around the aorta.
Maselli et al. monitored embolic events with a transcranial Doppler during 
minimally invasive mitral valve surgery, and found that brain embolism occurred 
predominantly at the time of ascending aorta clamping and declamping with an 
endoaortic balloon [17]. In the meantime, the application of an external cross-
clamp to the ascending aorta may cause the embolic events and traumatic injury.
The superiority between two methods of aortic cross-clamp has been 
controversial.
Kowalewski et al. performed a meta-analysis of observational studies [18]. They 
found that there was no difference of cerebrovascular events, all-cause mortality, 
and kidney injury between endoaortic and transthoracic cross-clamp; however, 
endoaortic balloon occlusion was associated with a higher risk of iatrogenic aortic 
dissection (0.93 vs. 0.13%) and higher risk of leg ischemia (0.47 vs. 0.20%) than 
transthoracic cross-clamp.
Kesavuori et al. reported their initial 5-year results of robotic mitral valve 
repairs [19]. The postoperative complications included conversion to sternotomy, 
reoperations for bleeding, and low cardiac output states requiring extracorporeal 
membrane oxygenation. They reported that early major robotic complications were 
related to the use of endoaortic balloon occlusion.
In the meantime, Barbero et al. reviewed three centers’ experience of minimally 
invasive mitral valve surgery, and did not find differences in respiratory failure, 
major vascular complication, stroke, and in-hospital mortality between endoaortic 
and transthoracic aortic clamping [20].
2.5 Myocardial protection
Although several ways of myocardial protection have been advocated in mini-
mally invasive mitral valve surgery, the optimal method has been controversial. 
There is a choice of antegrade or retrograde, intermittent or continuous, and 
crystalloid or blood cardioplegia.
One of the earliest approaches were antegrade cardioplegia via the endoaortic 
balloon, as described in the “aortic cross-clamp.” Lebon et al. compared 118 patients 
undergoing minimally invasive mitral valve surgery and 118 patients undergoing 
open mitral valve surgery, and found no difference in the incidence of difficult 
weaning from bypass and intra-aortic balloon pump use between two groups [21].
When applying transthoracic cross-clamp, direct cardioplegia insertion into the 
ascending aorta through a long antegrade cardioplegia catheter is necessary. As the 
insertion site of cardioplegia catheter gets far in the thoracotomy, the insertion and 
decannulation of the catheter can be associated with higher risk of bleeding than 
sternotomy.
In the setting of aortic insufficiency, retrograde cardioplegia might be desirable. 
Retrograde cardioplegia can be performed by placement of a percutaneous coronary 
sinus catheter via the internal jugular vein, but that requires specialized skills with 
an increased cost of a specialized catheter. In addition, the retrograde cardioplegia 
catheter insertion can cause catheter displacement, coronary sinus rupture, and 
inadequate protection of the right ventricle [22]. Another option of retrograde 
cardioplegia is to directly insert a catheter through a purse-string in the right atrium 
under a transesophageal echocardiography.
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There are two types of cardioplegia solution: crystalloid and blood. Blood 
cardioplegia is usually chosen in the open-heart surgery, as it has two advantages 
over pure crystalloid cardioplegia. First, blood cardioplegia can deliver oxygen to 
the myocardium, and secondly, the additional crystalloid volume is small; thus, 
hemodilution or myocardial edema can be avoided. Therefore, some centers still use 
blood cardioplegia in minimally invasive mitral valve surgery.
However, some centers prefer crystalloid-based cardioplegia: histidine-trypto-
phan-ketoglutarate cardioplegia [19, 23]. The advantage of this cardioplegia is that a 
single antegrade shot can maintain adequate myocardial protection up to 2 hours; thus, 
potentially aortic cross-clamp time and cardiopulmonary bypass time can be reduced.
2.6 Unilateral pulmonary edema
Unilateral pulmonary edema is known as an uncommon, but frequently lethal 
complication following minimally invasive robotic cardiac surgery. The clinical 
presentation of this condition includes severe right lung edema developing within 
the first several minutes to hours after coming off from a cardiopulmonary bypass 
(Figure 3), which leads to profound hypoxia, hypercapnia, pulmonary hyperten-
sion, and hemodynamic instability.
The mechanism of this condition is yet to be fully understood. Lung deflation is 
shown to be associated with the sequestration of inflammatory response. Minamiya 
et al. reported that during atelectasis, polymorphonuclear leukocytes accumulate in 
Figure 3. 
A typical chest X-ray imaging showing unilateral pulmonary edema on the right side.
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the lung, and after pulmonary reexpansion, polymorphonuclear leukocytes respira-
tory bursting occurs [24]. The inflammatory response may be aggravated by the use 
of cardiopulmonary bypass. It is reported that prolonged cardiopulmonary bypass 
time and lung collapse are associated with the occurrence of unilateral pulmonary 
edema. Other factors such as obesity and intraoperative blood product use may 
affect the inflammatory response.
Renner et al. reviewed their 256 patients who underwent minimally invasive 
mitral valve surgery, and they encountered five cases (2.0%) of unilateral pulmo-
nary edema, which required postoperative extracorporeal membrane oxygenation; 
two of them had in-hospital mortality [25]. They reported that preoperative high 
C-reactive protein and long cardiopulmonary bypass time were associated with the 
occurrence of unilateral pulmonary edema.
Irisawa et al. reviewed 381 patients who underwent minimally invasive cardiac 
surgery, and found 8 (2.1%) patients developed unilateral pulmonary edema [26]. 
They reported that preoperative use of steroid or immunosuppressive drugs and pro-
longed aortic cross-clamp time were the risk factors for unilateral pulmonary edema.
Keyl et al. reported that the use of dexamethasone significantly reduced the 
incidence of unilateral pulmonary edema from 12.9 to 4.0% [27]. Moss et al. 
reported their modifications to the robotic mitral valve repair technique in an effort 
to reduce the incidence of unilateral pulmonary edema [28]. They hypothesized that 
unilateral pulmonary edema results from severe right lung ischemia due to insuf-
ficient bronchial artery flow. Their modifications were focused on right lung oxygen 
supply, and included minimization of right rung deflation before cardiopulmonary 
bypass, infusion of unheated CO2 into the right chest, active cooling to low sys-
temic temperature, maintaining high mean arterial pressure during cardiopulmo-
nary bypass, and restoration of right lung ventilation was early as possible.
3. Conclusions
Although many reports demonstrated the efficacy and safety of robotic mitral 
valve repair, there are some specific pitfalls, which surgeons do not encounter in a 
conventional open heart surgery. In order to achieve a good success of robotic mitral 
valve repair, surgeons need to understand these particular issues and avoid robotic-
related complications.
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